References

1. 1.
   XU Y L， ZHAO J X， YANG L G. Epidemic status and risk factors of non-alcoholic fatty liver disease［J］.Chin Gen Pract， 2024， 27（30）： 3825-3834.
2. 2.
   MUNDI M S，VELAPATI S，PATEL J，et al. Evolution of NAFLD and its management［J］.Nutr Clin Pract，2020，35 （1）：72-84.
3. 3.
   LOOMBA R，FRIEDMAN S L，SHULMAN G I. Mechanisms and disease consequences of nonalcoholic fatty liver disease［J］.Cell，2021，184 （10）：2537-2564.
4. 4.
   FOLGUERAS A R，FREITAS-RODRÍGUEZ S，RAMSAY A J，et al.Matriptase-2 deficiency protects from obesity by modulating iron homeostasis［J］.Nat Commun，2018，9（1）：1350.
5. 5.
   HUANG C，FANG X G，CHEN L.Impact of atractylodin on ferroptosis in glioma cells by regulating the Nrf2/SLC7A11/GPX4 signaling pathway［J］.Hebei Med J，2024，46（3）： 325-329.
6. 6.
   FAN Y， DOU R P， HU J L， et al. Modulation of iron death by Poric acid through Nrf2/SLC7A11/GPX4 signal pathway in the improvement of cognitive impairment of Alzheimer's disease rats［J］.Chin Gen Pract， 2024， 27（2）： 177-183.
7. 7.
   BIAO Y N， ZHANG M Q， HAN X， et al. Danggui Shaoyao San regulates Keap1/Nrf2 signaling pathway in rats with nonalcoholic fatty liver disease［J］.Pharm Clin Chin Mater Med， 2022， 38（1）： 13-18.
8. 8.
   CHEN Q.Methodologyfor pharmacological research of traditional Chinese medicine［M］.Beiing：People's Medical Publishing House， 1993：1103-1104.
9. 9.
   LIU J J，DAI L，DONG L，et al.Effects of polydatin on nonalcoholic fatty liver and related molecular mechanisms［J］. Chin J Immunol， 2019， 35（10）： 1188-1191.
10. 10.
    XIAO Y X， LIU Y， XU L L， et al. Research progress on the role of ferroptosis in the pathogenesis of non-alcoholic fatty liver disease［J］. Basic Clin Med， 2024， 44（2）： 260-264.
11. 11.
    YE M Q，XUE J D，LI F P，et al.Study on regulation and mechanism of Huazhi Fugan granules onTLR4/NF-κB pathway and fatty iron death in non-alcoholic fatty liver［J］. Mod J Integr Tradit Chin West Med，2021，30（30）：3307-3312.
12. 12.
    YANG L T， XU T， YANG F Q， et al. Effect and mechanism of TFRC on ferroptosis induced by iron overloadin cardiac myocytes of rats［J］.Med J Chin People's Liber Army， 2022， 47（8）： 781-788.
13. 13.
    NATARAJ A，GOVINDAN S，RAMANI P，et al. Antioxidant，antitumour， and anticoagulant activities of polysaccharide from calocybe indica （APK2）［J］. Antioxidants （Basel）， 2022， 11（9）： 1694．
14. 14.
    TANG W J， LUO Y D， ZHU J R， et al. Icariin ameliorates heart failure by attenuating ferroptosis through theupregulation of the SLC7A11/GPX4 axis［J］. J Zunyi Med Univ， 2024， 47（3）： 211-217.
15. 15.
    YIN D P， GUO Z X. The mechanism of Nrf2 regulating oxidative stress in diabetesnephropathy［J］. Chin J Clin Res， 2023， 36（5）： 646-650.
16. 16.
    YUAN Y， ZHAI Y， CHEN J， et al. Kaempferol ameliorates oxygen-glucose deprivation/reoxygenation-induced neuronal ferroptosis by actvating Nrf2/SLC7A11/GPX4 axis［J］. Biomolecules， 2021， 11（7）：923.
17. 17.
    SUN M Y， QIN H W， LI Y J， et al. Xueguan Ruanhua pills improve atherosclerosis by inhibiting ferroptosis through the Nrf2/xCT/GPX4 pathway［J］.J Beijing Univ Tradit Chin Med， 2024， 47（3）： 383-393.
18. 18.
    ZHENG LL，GUO D Z.Effect of Buyang Huanwutang on ferroptosis in diabetic kidney disease mice［J］.Chin J Exp Tradit Med Form，2023，29（17）：34-41.
19. 19.
    WANG F F，CHEN B Y，LI Q.Tumulosic acid inhibits oxygen-glucose deprivation/reoxygenation-induced cardiomyocyte ferroptosis by regulating Nrf2/SLC7A11/GPX4 signaling pathway［J］.Chin J Integr Med Cardio-Cerebrovascular Dis， 2024， 22（2）： 267-273.
20. 20.
    JIANG X C，TIAN D Z，LIU Q，et al.Shenling Baizhusan improves spermatogenesis in hyperuricemia oligoasthenospermia mice by regulating Nrf2/ARE pathway［J］.Chin J Exp Tradit Med Form，2023，29（15）：22-30.
21. 21.
    GAO S L，CAI Q Q，JIN X J，et al. Impacts of icariin on high glucose-induced microglial ferroptosis by regulating Nrf2/SLC7A11/GPX4 signaling pathway［J］.Front Pharm Sci， 2022， 25（11）： 1878-1883.